跳至主要内容
临床试验/NL-OMON39987
NL-OMON39987
已完成
4 期

icotine Replacement Therapy in the Intensive Care Unit: a randomized, controlled pilot study. - NicGoWell

Ziekenhuisvoorzieningen Gelderse Vallei0 个研究点目标入组 47 人待定

概览

阶段
4 期
干预措施
未指定
疾病 / 适应症
icotine ontwenning
发起方
Ziekenhuisvoorzieningen Gelderse Vallei
入组人数
47
状态
已完成
最后更新
去年

概览

简要总结

Trial is onging in other countries

注册库
who.int
开始日期
待定
结束日期
2016年8月1日
最后更新
去年
研究类型
Interventional

研究者

发起方
Ziekenhuisvoorzieningen Gelderse Vallei

入排标准

入选标准

  • Any patient admitted to the intensive care unit must meet all of the following criteria to;be eligible for the study:;\- Critically ill active smoking patient;\- Being mechanically ventilated ;\- Start of study product application within 48 hours after ICU admission;\- Expected to be mechanically ventilated for more than 48 hours after start of application of the study product

排除标准

  • Any patient admitted to the intensive care unit meeting one or more of the following;criteria is not eligible for the study:;\- Patient younger than 18 years ;\- Patient or next of kin denying research authorization;\- Pregnancy;\- Breastfeeding women;\- History of chronic dementia or psychosis;\- (Acute) neurologic disease on admission, possibly confounding study objectives (TBI, stroke, ICH/SAH, seizures, meningitis, encephalitis, intracranial tumor);\- Patient receiving any form of NRT within two weeks before admission ;\- Patient not understanding Dutch;\- Patient with acute myocardial infarction;\- Patient with severe cardiac aritmia;\- Patient with unstable or deteriorating angina pectoris;\- Patient with generalized acute or chronic skin diseases interfering with NRT absorption;\- Patient with severe hearing deficiency;\- Moribund patient;\- Patient with known hypersensibility to nicotine or components of the transdermal therapeutic system;\- Patient with known hypersensibility to patches;\- Patient participating in an other study

结局指标

主要结局

未指定

相似试验